Authors: Indrova, M Bubenik, J Simova, J Vonka, V Nemeckova, S Mendoza, L Reinis, M

Citation: M. Indrova et al., Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines:In vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide, INT J MOL M, 7(1), 2001, pp. 97-100

Authors: Reinis, M Bruckova, M Graham, RR Vandasova, J Stankova, M Carr, JK

Citation: M. Reinis et al., Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic, AIDS RES H, 17(13), 2001, pp. 1305-1310

Authors: Mendoza, L Indrova, M Hajkova, R Reinis, M Smahel, M Vonka, V Bubenik, J Jandlova, T

Citation: L. Mendoza et al., Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth, FOL BIOL, 46(3), 2000, pp. 91-97

Authors: Simova, J Reinis, M Sobota, V Capkova, J Bubenik, J Jandlova, T

Citation: J. Simova et al., Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80, molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines, FOL BIOL, 46(1), 2000, pp. 11-15

Authors: Quinones-Mateu, ME Albright, JL Torre, V Reinis, M Vandasova, J Bruckova, M Arts, EJ

Citation: Me. Quinones-mateu et al., Molecular epidemiology of HIV type 1 isolates from the Czech Republic: Identification of an env E subtype case, AIDS RES H, 15(1), 1999, pp. 85-89

Authors: Hajkova, R Indrova, M Jandlova, T Bubenik, J Reinis, M

Citation: R. Hajkova et al., Interleukin 2 gene therapy of surgical minimal residual tumour disease: Characterization of cytolytic effector cells from tumour progressors and regressors, FOL BIOL, 45(6), 1999, pp. 227-231